Microbiome Research (25)
25 papers in the Microbiome topic, indexed by PF-Atlas from PubMed and global journals.
- Advances in understanding the role of NLRP3 inflammasome-mediated macrophage pyroptosis in the pathogenesis of silicosis. · Ecotoxicology and environmental safety · 2026
- Integrated Analysis of the Lung Microbiome and Metabolome Reveals Associations Between Amino Acid Metabolism and Pulmonary Fibrosis in a Bleomycin-Induced Mouse Model. · International journal of molecular sciences · 2026
- Gut microbiota dynamics and metabolic pathways associated with bleomycin-induced pulmonary fibrosis progression. · PeerJ · 2026
- Lung microbiome alterations in idiopathic pulmonary fibrosis and hypersensitivity pneumonitis: A systematic review with insights into microbiome-host interactions and the gut-lung axis. · Respiratory investigation · 2026
- The Gut-Lung Axis in Respiratory Diseases: Mechanisms, Microbiome Dysbiosis, and Therapeutic Implications. A Comprehensive Review. · Respiratory medicine · 2026
- Microbiome-innate immune crosstalk in acute exacerbation of idiopathic pulmonary fibrosis: an amplification framework. · Frontiers in immunology · 2026
- Bridging the gaps: the gut-lung axis and microbial metabolites in the pathogenesis and treatment of pulmonary fibrosis. · Frontiers in medicine · 2026
- Intestinal dysbiosis associates with silica-induced pulmonary fibrosis in mice via arginine and tryptophan pathways. · BMC microbiology · 2026
- Harnessing the lung microbiome for precision management of fibrotic lung disease. · Trends in molecular medicine · 2026
- Gut microbiota dysbiosis and metabolic abnormalities promote oxidative stress and fibrosis in idiopathic pulmonary fibrosis. · Scientific reports · 2026
- Research Progress on the Mechanisms of Gut Microbiota Dysbiosis Associated With Idiopathic Pulmonary Fibrosis: A Review. · Cureus · 2026
- Integrated analysis of gut microbiome and fecal metabolome reveals potential non-invasive biomarkers for early-stage silicosis. · Microbiology spectrum · 2026
- Gut Microbiota in Pulmonary Arterial Hypertension: Murine Models and Human Microbial Signatures, Pathogenic Mechanisms, and Emerging Therapeutic Avenues. · Comprehensive Physiology · 2026
- Preliminary exploration of the ability of HUC-MSCs to restore the lung microbiota and related metabolite disorders in IPF treatment: combining 16S sequencing and metabolite analysis. · Frontiers in microbiology · 2025
- Tissue-resident Klebsiella quasipneumoniae contributes to progression of idiopathic pulmonary fibrosis by triggering macrophages mitophagy in mice. · Cell death discovery · 2025
- The Lung Mycobiome in Idiopathic Interstitial Pneumonia, Collagen Tissue Disease-related Interstitial Lung Disease, and Sarcoidosis. · Medical mycology journal · 2025
- Lactiplantibacillus sp. LP03 alleviates pulmonary fibrosis by modulating gut microbiota and elevating host palmitoylethanolamide to suppress TGF-β1/Smad2/3-mediated EMT. · Frontiers in microbiology · 2025
- Pseudomonas aeruginosa-driven airway dysbiosis and machine learning prediction of acute exacerbations in non-cystic fibrosis bronchiectasis: a microbial-inflammatory signature approach. · BMC pulmonary medicine · 2025
- Antibiotic-Depleted Lung Microbiota Modulates Surfactant Proteins Expression and Reduces Experimental Silicosis. · Biomedical and environmental sciences : BES · 2025
- Activation of Sirt1 by acetate alleviates silicofibrosis: Contribution of the gut microbiota. · Ecotoxicology and environmental safety · 2025
- Metagenomic Analysis of Lung Microbiome in Patients With Interstitial Lung Diseases and Sarcoidosis: An Experimental Study. · Health science reports · 2025
- Jiawei Buyang Huanwu Decoction modulates gut microbiota and metabolic profiles in a rat model of idiopathic pulmonary fibrosis. · Frontiers in microbiology · 2025
- Lung-gut axis, intestinal microbiota, and pulmonary fibrosis: mechanisms and therapeutic potential. · Frontiers in microbiology · 2025
- The beneficial effects of Akkermansia muciniphila and its derivatives on pulmonary fibrosis. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2024
- The Role of Lung Microbiome in Fibrotic Interstitial Lung Disease-A Systematic Review. · Biomolecules · 2024
Medical disclaimer. Research listings are for information only and are not medical advice.